Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data

Por Carroll, Cathryn A, Fairman, Kathleen A, Lage, Maureen J
Publicado em 2014

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Por Fairman, Kathleen A, Davis, Lindsay E, Sclar, David A
Publicado no Ther Clin Risk Manag (2017)

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Por Molina, Kyle C, Fairman, Kathleen A, Sclar, David A
Publicado no Drug Healthc Patient Saf (2018)

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Por Fairman, Kathleen A., Davis, Lindsay E., Peckham, Alyssa M., Sclar, David A.
Publicado no Drugs Real World Outcomes (2018)

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration

Por Fairman, Kathleen A., Peckham, Alyssa M., Rucker, Michael L., Rucker, Jonah H., Sclar, David A.
Publicado no BMC Res Notes (2018)